These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33868363)

  • 41. A Stochastic Multi-Attribute Method for Measuring Sustainability Performance of a Supplier Based on a Triple Bottom Line Approach in a Dual Hesitant Fuzzy Linguistic Environment.
    Qu G; Xue R; Li T; Qu W; Xu Z
    Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32210146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combining clinicopathological predictors and molecular biomarkers in the oncogenic K-RAS/Ki67/HIF-1α pathway to predict survival in resectable pancreatic cancer.
    Qin R; Smyrk TC; Reed NR; Schmidt RL; Schnelldorfer T; Chari ST; Petersen GM; Tang AH
    Br J Cancer; 2015 Feb; 112(3):514-22. PubMed ID: 25584484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells.
    Martinelli E; Troiani T; D'Aiuto E; Morgillo F; Vitagliano D; Capasso A; Costantino S; Ciuffreda LP; Merolla F; Vecchione L; De Vriendt V; Tejpar S; Nappi A; Sforza V; Martini G; Berrino L; De Palma R; Ciardiello F
    Int J Cancer; 2013 Nov; 133(9):2089-101. PubMed ID: 23629727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Petri net siphon analysis and graph theoretic measures for identifying combination therapies in cancer.
    Behinaein B; Rudie K; Sangrar W
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(1):231-243. PubMed ID: 28113516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systems pharmacology approaches for optimization of antiangiogenic therapies: challenges and opportunities.
    Sharan S; Woo S
    Front Pharmacol; 2015; 6():33. PubMed ID: 25750626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current Trends in Multidrug Optimization: An Alley of Future Successful Treatment of Complex Disorders.
    Weiss A; Nowak-Sliwinska P
    SLAS Technol; 2017 Jun; 22(3):254-275. PubMed ID: 28027446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics.
    Lang L; Shay C; Zhao X; Teng Y
    J Exp Clin Cancer Res; 2017 Aug; 36(1):112. PubMed ID: 28830537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A fractional-factorial probabilistic-possibilistic optimization framework for planning water resources management systems with multi-level parametric interactions.
    Wang S; Huang GH; Zhou Y
    J Environ Manage; 2016 May; 172():97-106. PubMed ID: 26922500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel fuzzy modeling and energy-saving predictive control of coordinated control system in 1000 MW ultra-supercritical unit.
    Hou G; Gong L; Huang C; Zhang J
    ISA Trans; 2019 Mar; 86():48-61. PubMed ID: 30420140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toll-like receptor 9 agonist IMO cooperates with cetuximab in K-ras mutant colorectal and pancreatic cancers.
    Rosa R; Melisi D; Damiano V; Bianco R; Garofalo S; Gelardi T; Agrawal S; Di Nicolantonio F; Scarpa A; Bardelli A; Tortora G
    Clin Cancer Res; 2011 Oct; 17(20):6531-41. PubMed ID: 21890455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anticancer therapeutics: "Addictive" targets, multi-targeted drugs, new drug combinations.
    Broxterman HJ; Georgopapadakou NH
    Drug Resist Updat; 2005 Aug; 8(4):183-97. PubMed ID: 16154800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting.
    Alshaker H; Wang Q; Brewer D; Pchejetski D
    Front Pharmacol; 2019; 10():303. PubMed ID: 30971929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of HGF/MET axis in resistance of lung cancer to contemporary management.
    Raghav KP; Gonzalez-Angulo AM; Blumenschein GR
    Transl Lung Cancer Res; 2012 Sep; 1(3):179-93. PubMed ID: 25806180
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current Trends in Multidrug Optimization.
    Weiss A; Nowak-Sliwinska P
    J Lab Autom; 2016 Dec; ():2211068216682338. PubMed ID: 28095178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Automated fluence map optimization based on fuzzy inference systems.
    Dias J; Rocha H; Ventura T; Ferreira B; Lopes Mdo C
    Med Phys; 2016 Mar; 43(3):1083-95. PubMed ID: 26936696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Morphoproteomics: a novel approach to identify potential therapeutic targets in cancer patients.
    Tan D
    Int J Clin Exp Pathol; 2008 Jan; 1(4):331-2. PubMed ID: 18787617
    [No Abstract]   [Full Text] [Related]  

  • 58. Light-initiated aggregation of gold nanoparticles for synergistic chemo-photothermal tumor therapy.
    Xia H; Zhu J; Men C; Wang A; Mao Q; Feng Y; Li J; Xu J; Cheng X; Shi H
    Nanoscale Adv; 2023 May; 5(11):3053-3062. PubMed ID: 37260491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combinational therapeutics to combat cancer.
    Otaibi AA; Sherwani S; Alshammari EM; Al-Zahrani SA; Khan WA; Dhahi Alsukaibi AK; Dwivedi S; Khan SN; Khan MWA
    Bioinformation; 2021; 17(7):673-679. PubMed ID: 35283582
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening for Combination Cancer Therapies With Dynamic Fuzzy Modeling and Multi-Objective Optimization.
    Spolaor S; Scheve M; Firat M; Cazzaniga P; Besozzi D; Nobile MS
    Front Genet; 2021; 12():617935. PubMed ID: 33868363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.